Investigating the role of aging cells in Alzheimer's disease

Cellular senescence and Alzheimer's disease

NIH-funded research Buck Institute for Research on Aging · NIH-10875692

This study is looking at how aging cells might affect the brain and contribute to Alzheimer's disease, and it’s testing a new type of medicine that could help get rid of these aging cells to improve brain health.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBuck Institute for Research on Aging NIH-funded
Lab location1 site (Novato, United States)
Project IDNIH-10875692 on NIH RePORTER

What this research studies

This research explores how aging cells, particularly senescent cells, contribute to the progression of Alzheimer's disease. It focuses on understanding the effects of these cells on neighboring healthy cells and how they may influence brain function. The study utilizes advanced 3D cell culture techniques and animal models to test the effectiveness of senolytic drugs, which are designed to eliminate senescent cells. By examining these interactions, the research aims to uncover new therapeutic strategies for Alzheimer's and related dementias.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or related dementias, particularly those experiencing cognitive decline.

Not a fit: Patients with early-stage Alzheimer's or those without significant cognitive impairment may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve brain health and cognitive function in patients with Alzheimer's disease.

How similar studies have performed: Previous studies have shown promising results using senolytic drugs in animal models, indicating potential for success in this novel approach.

Where this research is happening

Novato, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementia
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.